CMSC, Inc. (TPEX:7707)

Market Cap	3.85B
Revenue (ttm)	753.27M
Net Income (ttm)	192.78M
Shares Out	45.70M
EPS (ttm)	4.20
PE Ratio	20.05
Forward PE	n/a
Dividend	2.00 (2.27%)
Ex-Dividend Date	Jul 14, 2025

Volume	59,764
Average Volume	78,332
Open	83.80
Previous Close	84.20
Day's Range	82.30 - 86.00
52-Week Range	75.10 - 201.50
Beta	n/a
RSI	35.48
Earnings Date	Aug 25, 2025

About Theseus Pharmaceuticals

CMSC, Inc. designs and manufactures integrated circuits in Taiwan, Japan, South Korea, and internationally. The company’s product portfolio includes modules, system-in-packages, PCBs, and customized systems, as well as engages in the physical design, optimization, and SOC integration service; analog IC front-end and back-end design service; and IC chip engineering and mass production management. It also offers system-on-chip and ASIC design services; IP solutions; and process migration services. The company was founded in 1990 and is based in H...

• Industry: Semiconductors
• Sector: Technology
• Founded: 1990
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7707

Financial Performance

In 2024, CMSC, Inc.'s revenue was 753.27 million, a decrease of -0.99% compared to the previous year's 760.81 million. Earnings were 192.78 million, an increase of 2.64%.